Kamada Ltd.

KMDA

Cena:

$ 7.83

+0.01 (0.13%)

Valuace

Růst

Zdraví

Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři

Souhrn

Finanční data

Pro investory

Předpovědi

Zprávy

Dividendy

Zisky

Návštěvnost webu

Akcionáři

Zprávy

Zahraniční články

Tiskové zprávy

Dokumenty ke stáhnutí

Kamada Q1 Earnings Call Highlights

12:07 13-05-2026

Kamada NASDAQ: KMDA reiterated its full-year 2026 outlook after reporting first-quarter results that...

Kamada Ltd. (KMDA) Q1 2026 Earnings Call Transcript

11:30 13-05-2026

Kamada Ltd. (KMDA) Q1 2026 Earnings Call Transcript...

Kamada (KMDA) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

10:30 13-05-2026

Although the revenue and EPS for Kamada (KMDA) give a sense of how its business performed in the qua...

Kamada Reports First Quarter 2026 Financial Results and Affirms 2026 Annual Guidance; Expecting Significantly Stronger Remainder of the Year

7:00 13-05-2026

Q1-2026 Revenue of $45.2 Million, up 3% Year-over-Year; Adjusted EBITDA of $11.6 Million, representi...

Stay Ahead of the Game With Kamada (KMDA) Q1 Earnings: Wall Street's Insights on Key Metrics

10:17 08-05-2026

Get a deeper insight into the potential performance of Kamada (KMDA) for the quarter ended March 202...

Kamada to Announce First Quarter 2026 Financial Results on May 13, 2026

7:00 06-05-2026

REHOVOT, Israel and HOBOKEN, N.J., May 06, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd....

Kamada Announces FDA Approval of its Plasma Collection Center in San Antonio, Texas

7:00 26-03-2026

REHOVOT, Israel and HOBOKEN, N.J., March 26, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TA...

Kamada Ltd. (KMDA) Q4 2025 Earnings Call Transcript

10:52 11-03-2026

Kamada Ltd. (KMDA) Q4 2025 Earnings Call Transcript...

Kamada (KMDA) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

10:31 11-03-2026

Although the revenue and EPS for Kamada (KMDA) give a sense of how its business performed in the qua...

Kamada (KMDA) Q4 Earnings and Revenues Miss Estimates

9:16 11-03-2026

Kamada (KMDA) came out with quarterly earnings of $0.06 per share, missing the Zacks Consensus Estim...

Kamada Reports Record Top- and Bottom-line 2025 Financial Results and Affirms 2026 Guidance Representing Continued Double-Digit Organic Profitable Growth

7:02 11-03-2026

REHOVOT, Israel, and HOBOKEN, N.J., March 11, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TA...

Kamada Declares Cash Dividend of $0.25 Per Share, to be Paid in Accordance with an Adopted Annual Cash Dividend Policy

7:00 11-03-2026

REHOVOT, Israel and HOBOKEN, N.J., March 11, 2026 (GLOBE NEWSWIRE) -- Kamada Ltd....

Ahead of Kamada (KMDA) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics

10:15 06-03-2026

Besides Wall Street's top-and-bottom-line estimates for Kamada (KMDA), review projections for some o...

KMDA vs. ARGX: Which Stock Is the Better Value Option?

12:40 05-03-2026

Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably alrea...

KMDA or TECH: Which Is the Better Value Stock Right Now?

12:40 17-02-2026

Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Kamada (KM...

Kamada (KMDA) Soars 8.1%: Is Further Upside Left in the Stock?

9:25 27-01-2026

Kamada (KMDA) witnessed a jump in share price last session on above-average trading volume. The late...

Kamada (NASDAQ:KMDA) Stock Crosses Above 50 Day Moving Average – Here’s Why

5:12 06-01-2026

Kamada Ltd. (NASDAQ: KMDA - Get Free Report)'s share price crossed above its fifty day moving averag...

Kamada Announces a $10-$14 Million Extension of Canadian Supply Tender

7:00 18-12-2025

REHOVOT, Israel, and HOBOKEN, N.J., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TAS...

Kamada Shuts Down Phase 3 Study For Genetic Condition, Reiterates Outlook

11:05 08-12-2025

Kamada Ltd. (NASDAQ: KMDA) on Monday said it will discontinue its Phase 3 InnovAATe trial of Inhaled...

Kamada Ltd. (KMDA) Discusses Discontinuation of Phase 3 Inhaled AAT Clinical Trial and Financial Outlook Transcript

9:26 08-12-2025

Kamada Ltd. (KMDA) Discusses Discontinuation of Phase 3 Inhaled AAT Clinical Trial and Financial Out...

KAMADA ANNOUNCES A $10-$14 MILLION EXTENSION OF CANADIAN SUPPLY TENDER

18-12-2025

REHOVOT, ISRAEL, AND HOBOKEN, N.J., DEC. 18, 2025 (GLOBE NEWSWIRE) -- KAMADA LTD. (NASDAQ: KMDA; TAS...

Více zde

KAMADA REPORTS STRONG THIRD QUARTER AND NINE MONTH 2025 FINANCIAL RESULTS WITH OVER 30% YEAR-OVER-YEAR PROFITABILITY GROWTH

10-11-2025

REHOVOT, ISRAEL, AND HOBOKEN, N.J., NOV. 10, 2025 (GLOBE NEWSWIRE) -- KAMADA LTD. (NASDAQ: KMDA; TAS...

Více zde

KAMADA TO ANNOUNCE THIRD QUARTER AND NINE MONTHS ENDED SEPTEMBER 30, 2025 FINANCIAL RESULTS ON NOVEMBER 10, 2025

03-11-2025

REHOVOT, ISRAEL AND HOBOKEN, N.J., NOV. 03, 2025 (GLOBE NEWSWIRE) -- KAMADA LTD....

Více zde

KAMADA TO ANNOUNCE SECOND QUARTER AND FIRST HALF ENDED JUNE 30, 2025 FINANCIAL RESULTS ON AUGUST 13, 2025

06-08-2025

REHOVOT, ISRAEL, AND HOBOKEN, N.J., AUG. 06, 2025 (GLOBE NEWSWIRE) -- KAMADA LTD....

Více zde

KAMADA CONFIRMS CONTINUOUS GLOBAL BUSINESS OPERATIONS AND PRODUCTS AVAILABILITY DESPITE RECENT EVENTS IN THE MIDDLE EAST

17-06-2025

REHOVOT, ISRAEL AND HOBOKEN, N.J., JUNE 17, 2025 (GLOBE NEWSWIRE) -- KAMADA LTD. (NASDAQ: KMDA; TASE...

Více zde

KAMADA REPORTS STRONG FIRST QUARTER 2025 FINANCIAL RESULTS WITH YEAR OVER YEAR TOP LINE GROWTH OF 17% AND A 54% INCREASE IN PROFITABILITY

14-05-2025

REHOVOT, ISRAEL AND HOBOKEN, N.J., MAY 14, 2025 (GLOBE NEWSWIRE) -- KAMADA LTD. (NASDAQ: KMDA; TASE:...

Více zde

KAMADA ANNOUNCES EXPANSION OF PLASMA COLLECTION OPERATIONS WITH THE OPENING OF NEW SITE IN SAN ANTONIO, TEXAS

19-03-2025

REHOVOT, ISRAEL AND HOBOKEN, N.J., MARCH 19, 2025 (GLOBE NEWSWIRE) -- KAMADA LTD. (NASDAQ: KMDA; TAS...

Více zde

KAMADA REPORTS RECORD TOP AND BOTTOM LINE 2024 FINANCIAL RESULTS AND AFFIRMS 2025 GUIDANCE REPRESENTING DOUBLE-DIGIT PROFITABLE GROWTH

05-03-2025

REHOVOT, ISRAEL, AND HOBOKEN, N.J., MARCH 05, 2025 (GLOBE NEWSWIRE) -- KAMADA LTD. (NASDAQ: KMDA; TA...

Více zde

KAMADA TO ANNOUNCE FOURTH QUARTER AND FISCAL YEAR 2024 FINANCIAL RESULTS ON MARCH 5, 2025

26-02-2025

REHOVOT, ISRAEL, AND HOBOKEN, N.J., FEB. 26, 2025 (GLOBE NEWSWIRE) -- KAMADA LTD....

Více zde

KAMADA ANNOUNCES A $25 MILLION 3-YEAR CONTRACT FOR SUPPLY OF KAMRAB® AND VARIZIG® IN LATIN AMERICA

22-01-2025

REHOVOT, ISRAEL AND HOBOKEN, N.J., JAN. 22, 2025 (GLOBE NEWSWIRE) -- KAMADA LTD. (NASDAQ: KMDA; TASE...

Více zde

KAMADA ANNOUNCES EXPANSION OF PLASMA COLLECTION OPERATIONS IN TEXAS WITH THE OPENING OF NEW SITE IN HOUSTON

23-09-2024

REHOVOT, ISRAEL AND HOBOKEN, N.J., SEPT. 23, 2024 (GLOBE NEWSWIRE) -- KAMADA LTD. (NASDAQ: KMDA; TAS...

Více zde

KAMADA TO ANNOUNCE SECOND QUARTER AND FIRST HALF ENDED JUNE 30, 2024 FINANCIAL RESULTS AND HOST CONFERENCE CALL ON AUGUST 14, 2024

07-08-2024

REHOVOT, ISRAEL, AND HOBOKEN, N.J., AUG. 07, 2024 (GLOBE NEWSWIRE) -- KAMADA LTD. (NASDAQ: KMDA; TAS...

Více zde

KAMADA REPORTS STRONG FIRST QUARTER 2024 FINANCIAL RESULTS WITH YEAR-OVER-YEAR TOP-LINE GROWTH OF 23% AND A 96% INCREASE IN PROFITABILITY; RAISES FULL-YEAR FINANCIAL GUIDANCE

08-05-2024

REHOVOT, ISRAEL AND HOBOKEN, N.J., MAY 08, 2024 (GLOBE NEWSWIRE) -- KAMADA LTD. (NASDAQ: KMDA; TASE:...

Více zde

KAMADA TO ANNOUNCE FIRST QUARTER 2024 FINANCIAL RESULTS AND HOST CONFERENCE CALL ON MAY 8, 2024

01-05-2024

REHOVOT, ISRAEL AND HOBOKEN, N.J., MAY 01, 2024 (GLOBE NEWSWIRE) -- KAMADA LTD. (NASDAQ: KMDA; TASE:...

Více zde

KAMADA ISSUES 2024 CEO LETTER TO SHAREHOLDERS

06-03-2024

REHOVOT, ISRAEL, AND HOBOKEN, N.J., MARCH 06, 2024 (GLOBE NEWSWIRE) -- KAMADA LTD. (NASDAQ: KMDA; TA...

Více zde

KAMADA REPORTS STRONG FISCAL YEAR AND FOURTH QUARTER 2023 FINANCIAL RESULTS, AND PROVIDES FULL-YEAR 2024 GUIDANCE REPRESENTING DOUBLE-DIGIT GROWTH IN REVENUE AND PROFITABILITY

06-03-2024

REHOVOT, ISRAEL, AND HOBOKEN, N.J., MARCH 06, 2024 (GLOBE NEWSWIRE) -- KAMADA LTD. (NASDAQ: KMDA; TA...

Více zde

KAMADA TO ANNOUNCE FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIAL RESULTS, AND PROVIDE 2024 FINANCIAL GUIDANCE ON MARCH 6, 2024

28-02-2024

REHOVOT, ISRAEL, AND HOBOKEN, N.J., FEB. 28, 2024 (GLOBE NEWSWIRE) -- KAMADA LTD....

Více zde

PRISM MARKETVIEW BIOTECH INDEX TOP MOVER SPOTLIGHT: KAMADA (KMDA)

07-12-2023

NEW YORK, NY, DECEMBER 07, 2023 – PRISM MARKETVIEW, A LEADING PROVIDER OF UNBIASED MARKET INSIGHT ...

Více zde

KEDRION ANNOUNCES AN EIGHT-YEAR EXTENSION OF THE DISTRIBUTION AGREEMENT WITH KAMADA IN THE US FOR KEDRAB®

07-12-2023

SINCE 2018 KEDRION HAS HAD EXCLUSIVE DISTRIBUTION RIGHTS IN THE US FOR KEDRAB®, A HUMAN RABIES IMMU...

Více zde

KAMADA ANNOUNCES ITS LARGEST COMMERCIAL AGREEMENT; A STRATEGIC ENGAGEMENT WITH KEDRION FOR U.S. DISTRIBUTION OF KEDRAB® INCLUDING $180 MILLION OF REVENUES OVER FIRST FOUR YEARS

06-12-2023

REHOVOT, ISRAEL AND HOBOKEN, N.J., DEC. 06, 2023 (GLOBE NEWSWIRE) -- KAMADA LTD. (NASDAQ: KMDA; TASE...

Více zde

KAMADA REPORTS SIGNIFICANT INCREASE IN SALES AND PROFITABILITY IN THE THIRD QUARTER AND NINE MONTH 2023; REITERATES 2023 REVENUE AND PROFITABILITY GUIDANCE

13-11-2023

REHOVOT, ISRAEL AND HOBOKEN, N.J., NOV. 13, 2023 (GLOBE NEWSWIRE) -- KAMADA LTD. (NASDAQ: KMDA; TASE...

Více zde

KAMADA TO ANNOUNCE THIRD QUARTER AND FIRST NINE MONTHS ENDED SEPTEMBER 30, 2023 FINANCIAL RESULTS AND HOST CONFERENCE CALL ON NOVEMBER 13, 2023

08-11-2023

REHOVOT, ISRAEL, AND HOBOKEN, N.J., NOV. 08, 2023 (GLOBE NEWSWIRE) -- KAMADA LTD. (NASDAQ & TASE: KM...

Více zde

KAMADA PROVIDES CORPORATE UPDATE ON ITS ISRAEL OPERATIONS

10-10-2023

REHOVOT, ISRAEL, AND HOBOKEN, N.J., OCT. 10, 2023 (GLOBE NEWSWIRE) -- KAMADA LTD. (NASDAQ: KMDA; TAS...

Více zde

KAMADA ANNOUNCES SHAREHOLDER APPROVAL AND PLANNED CLOSING OF $60 MILLION PRIVATE PLACEMENT WITH FIMI OPPORTUNITY FUNDS

30-08-2023

REHOVOT, ISRAEL AND HOBOKEN, N.J., AUG. 30, 2023 (GLOBE NEWSWIRE) -- KAMADA LTD. (NASDAQ: KMDA; TASE...

Více zde

KAMADA REPORTS STRONG SECOND QUARTER AND FIRST HALF 2023 FINANCIAL RESULTS; REITERATES 2023 REVENUE AND PROFITABILITY GUIDANCE

16-08-2023

REHOVOT, ISRAEL AND HOBOKEN, N.J., AUG. 16, 2023 (GLOBE NEWSWIRE) -- KAMADA LTD. (NASDAQ: KMDA; TASE...

Více zde

KAMADA TO ANNOUNCE SECOND QUARTER AND FIRST HALF ENDED JUNE 30, 2023 FINANCIAL RESULTS AND HOST CONFERENCE CALL ON AUGUST 16, 2023

09-08-2023

REHOVOT, ISRAEL AND HOBOKEN, N.J., AUG. 09, 2023 (GLOBE NEWSWIRE) -- KAMADA LTD. (NASDAQ & TASE: KMD...

Více zde

KAMADA ANNOUNCES KEDRION EXERCISED ITS OPTION FOR TWO-YEAR EXTENSION OF KEDRAB® DISTRIBUTION AGREEMENT IN THE U.S.

12-07-2023

REHOVOT, ISRAEL, AND HOBOKEN, N.J., JULY 12, 2023 (GLOBE NEWSWIRE) -- KAMADA LTD. (NASDAQ: KMDA; TAS...

Více zde

KAMADA REPORTS STRONG FIRST QUARTER 2023 FINANCIAL RESULTS; REITERATES REVENUE AND PROFITABILITY GUIDANCE

24-05-2023

REHOVOT, ISRAEL AND HOBOKEN, N.J., MAY 24, 2023 (GLOBE NEWSWIRE) -- KAMADA LTD. (NASDAQ: KMDA; TASE:...

Více zde

KAMADA ANNOUNCES CHIEF FINANCIAL OFFICER CHAIME ORLEV TO REMAIN IN ROLE AND APPOINTMENT OF NIR LIVNEH AS VICE PRESIDENT, GENERAL COUNSEL AND CORPORATE SECRETARY

24-05-2023

REHOVOT, ISRAEL AND HOBOKEN, N.J., MAY 24, 2023 (GLOBE NEWSWIRE) -- KAMADA LTD. (NASDAQ: KMDA; TASE:...

Více zde

KAMADA ANNOUNCES $60 MILLION PRIVATE PLACEMENT WITH FIMI OPPORTUNITY FUNDS

24-05-2023

FUNDING TO SUPPORT KAMADA'S GROWTH PLANS AND EXECUTION OF STRATEGIC BUSINESS DEVELOPMENT OPPORTUNITI...

Více zde

Dokumenty nejsou k dispozici